298 related articles for article (PubMed ID: 19127447)
1. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.
Bahat-Stroomza M; Barhum Y; Levy YS; Karpov O; Bulvik S; Melamed E; Offen D
J Mol Neurosci; 2009 Sep; 39(1-2):199-210. PubMed ID: 19127447
[TBL] [Abstract][Full Text] [Related]
2. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
3. Implantation of glial cell line-derived neurotrophic factor-expressing adipose tissue-derived stromal cells in a rat Parkinson's disease model.
Xu R; Wu J; Lang L; Hu J; Tang H; Xu J; Sun B
Neurol Res; 2020 Aug; 42(8):712-720. PubMed ID: 32567526
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
Sadan O; Bahat-Stromza M; Barhum Y; Levy YS; Pisnevsky A; Peretz H; Ilan AB; Bulvik S; Shemesh N; Krepel D; Cohen Y; Melamed E; Offen D
Stem Cells Dev; 2009 Oct; 18(8):1179-90. PubMed ID: 19243240
[TBL] [Abstract][Full Text] [Related]
5. Differentiated mesenchymal stem cells for sciatic nerve injury.
Dadon-Nachum M; Sadan O; Srugo I; Melamed E; Offen D
Stem Cell Rev Rep; 2011 Sep; 7(3):664-71. PubMed ID: 21327572
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity.
Ganapathy K; Datta I; Bhonde R
Mol Neurobiol; 2019 Jun; 56(6):4395-4413. PubMed ID: 30327976
[TBL] [Abstract][Full Text] [Related]
7. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
10. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.
Khoo ML; Tao H; Meedeniya AC; Mackay-Sim A; Ma DD
PLoS One; 2011; 6(5):e19025. PubMed ID: 21625433
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat.
Ye M; Chen S; Wang X; Qi C; Lu G; Liang L; Xu J
Neuroreport; 2005 Apr; 16(6):581-4. PubMed ID: 15812312
[TBL] [Abstract][Full Text] [Related]
13. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease.
Xiong N; Zhang Z; Huang J; Chen C; Zhang Z; Jia M; Xiong J; Liu X; Wang F; Cao X; Liang Z; Sun S; Lin Z; Wang T
Gene Ther; 2011 Apr; 18(4):394-402. PubMed ID: 21107440
[TBL] [Abstract][Full Text] [Related]
14. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
Glavaski-Joksimovic A; Virag T; Mangatu TA; McGrogan M; Wang XS; Bohn MC
J Neurosci Res; 2010 Sep; 88(12):2669-81. PubMed ID: 20544825
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
[TBL] [Abstract][Full Text] [Related]
16. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
17. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.
Sun Y; Lu XJ; Fu X; Zhang Y; Zhan Y; Liu J; Zhao L; Xia CL
Mol Cell Biochem; 2021 Feb; 476(2):619-631. PubMed ID: 33070275
[TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.
Ming M; Li X; Fan X; Yang D; Li L; Chen S; Gu Q; Le W
J Transl Med; 2009 Jun; 7():53. PubMed ID: 19558709
[TBL] [Abstract][Full Text] [Related]
19. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
[TBL] [Abstract][Full Text] [Related]
20. Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations.
Mei J; Niu C
Mol Med Rep; 2015 Feb; 11(2):1207-13. PubMed ID: 25373844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
